UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control

PLoS pathogens, 2016-01, Vol.12 (1), p.e1005315-e1005315

2016

Link zum Volltext

Verfügbarkeit prüfen

Multi-isotype Glycoproteomic Characterization of Serum Antibody Heavy Chains Reveals Isotype- and Subclass-Specific N-Glycosylation Profiles[S]

Molecular & cellular proteomics, 2019-04, Vol.18 (4), p.686-703

2019

Link zum Volltext

Verfügbarkeit prüfen

A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus

Cell host & microbe, 2018-08, Vol.24 (2), p.221-233.e5

2018

Link zum Volltext

Verfügbarkeit prüfen

Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines

Science translational medicine, 2014-03, Vol.6 (228), p.228ra38

2014

Link zum Volltext

Verfügbarkeit prüfen

Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

The Journal of experimental medicine, 2007-11, Vol.204 (12), p.3027-3036

2007

Link zum Volltext

Verfügbarkeit prüfen

Beyond binding: antibody effector functions in infectious diseases

Nature reviews. Immunology, 2018-01, Vol.18 (1), p.46

2018

Link zum Volltext

Verfügbarkeit prüfen

Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors

AIDS (London), 2018-02, Vol.32 (4), p.443-450

2018

Link zum Volltext

Verfügbarkeit prüfen

Lack of protection following passive transfer of polyclonal highly functional low-dose non-neutralizing antibodies

PloS one, 2014-05, Vol.9 (5), p.e97229-e97229

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics

PloS one, 2022-06, Vol.17 (6), p.e0267796-e0267796

2022

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates

Cell reports (Cambridge), 2023-04, Vol.42 (4), p.112402-112402, Article 112402

2023

Link zum Volltext

Verfügbarkeit prüfen

Exploiting glycan topography for computational design of Env glycoprotein antigenicity

PLoS computational biology, 2018-04, Vol.14 (4), p.e1006093-e1006093

2018

Link zum Volltext

Verfügbarkeit prüfen

HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound

Cell reports (Cambridge), 2020-12, Vol.33 (11), p.108502-108502, Article 108502

2020

Link zum Volltext

Verfügbarkeit prüfen

Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees

PLoS computational biology, 2015-04, Vol.11 (4), p.e1004185-e1004185

2015

Link zum Volltext

Verfügbarkeit prüfen

Type‐1 immunity drives early lethality in scurfy mice

European journal of immunology, 2012-09, Vol.42 (9), p.2305-2310

2012

Link zum Volltext

Verfügbarkeit prüfen

Receptor-Ligand Requirements for Increased NK Cell Polyfunctional Potential in Slow Progressors Infected with HIV-1 Coexpressing KIR3DL1h/y and HLA-B57

Journal of Virology, 2011-06, Vol.85 (12), p.5949-5960

2011

Link zum Volltext

Verfügbarkeit prüfen

A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation

Journal of immunological methods, 2019-10, Vol.473, p.112630-112630, Article 112630

2019

Link zum Volltext

Verfügbarkeit prüfen

Extensive HLA class I allele promiscuity among viral CTL epitopes

European journal of immunology, 2007-09, Vol.37 (9), p.2419-2433

2007

Link zum Volltext

Verfügbarkeit prüfen

Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells

Journal of Immunology, 2007-06, Vol.178 (12), p.7658-7666

2007

Link zum Volltext

Verfügbarkeit prüfen

Distinct Early Serological Signatures Track with SARS-CoV-2 Survival

Immunity (Cambridge, Mass.), 2020-09, Vol.53 (3), p.524-532.e4

2020

Link zum Volltext

Verfügbarkeit prüfen

Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid

Journal of Virology, 2008-06, Vol.82 (11), p.5594-5605

2008

Link zum Volltext

Verfügbarkeit prüfen

Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design

Annual review of medicine, 2016-01, Vol.67 (1), p.185-200

2016

Link zum Volltext

Verfügbarkeit prüfen

Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands

AIDS (London), 2008-03, Vol.22 (5), p.655-658

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(74)
Buchkapitel
(1)

Sprache

Englisch
(75)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control

Fc Glycan-Mediated Regulation of Placental Antibody Transfer

Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology

Multi-isotype Glycoproteomic Characterization of Serum Antibody Heavy Chains Reveals Isotype- and Subclass-Specific N-Glycosylation Profiles[S]

A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus

Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

Beyond binding: antibody effector functions in infectious diseases

Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors

Lack of protection following passive transfer of polyclonal highly functional low-dose non-neutralizing antibodies

Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics

Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates

Exploiting glycan topography for computational design of Env glycoprotein antigenicity

HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound

Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees

Type‐1 immunity drives early lethality in scurfy mice

Receptor-Ligand Requirements for Increased NK Cell Polyfunctional Potential in Slow Progressors Infected with HIV-1 Coexpressing KIR3DL1h/y and HLA-B57

A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation

Extensive HLA class I allele promiscuity among viral CTL epitopes

Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells

Distinct Early Serological Signatures Track with SARS-CoV-2 Survival

Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid

Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design

Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands

Suchergebnisse filtern